Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Rooster Bio Appoints Chien Chien Jacques As Chief Financial Officer

PRIVATESep 20, 2024•over 1 year ago

Position

Chief Financial Officer

Company

RoosterBio

Chien-Chien Jacques

FrederickBiotechnology

Description

RoosterBio has appointed Chien-Chien “CC” Jacques as its new Chief Financial Officer, where she will oversee financial operations as the company advances next-generation stem cell therapies and continues its rapid growth in the regenerative medicine field.

Company Information

Company

RoosterBio

Location

4539 METROPOLITAN COURT

Frederick, Maryland, United States

About

RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable Regenerative Medicine industry, one customer at a time. RoosterBio's products are high-volume, cost-effective, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how living cells are purchased, expanded, and used in development, leading to marked time and cost savings for customers. RoosterBio's innovative products and collaborative relationships are ushering in a new era of productivity and standardization into the field.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for RoosterBio's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months